Kishan Mehta
Fortune : 249 509 $ au 31/05/2026
Fortune : 249 509 $ au 31/05/2026
Kishan C.
Mehta is the founder of Social Capital Suvretta Holdings Corp.
I, founded in 2021, serving as President & Director.
Mr. Mehta was the founder of Social Capital Suvretta Holdings Corp.
II, founded in 2021, serving as President & Director.
Mr. Mehta was the founder of Social Capital Suvretta Holdings Corp.
IV, founded in 2021, serving as President & Director.
Mr. Mehta currently serves as Director at Biohaven Ltd. since 2022.
Mr. Mehta currently serves as Independent Director at Benitec Biopharma, Inc. since 2024.
Former positions included Director at Biohaven Pharmaceutical Holding Co. Ltd. from 2021 to 2022, President & Director at ProKidney Corp.
from 2021 to 2022, Director at Akili, Inc. from 2021 to 2022, President & Director at Social Capital Suvretta Holdings Corp.
III from 2021 to 2022, Analyst at Adage Capital Management LP, Analyst at Evercore, Inc. in 2010, Analyst at BBT Capital Management, Inc. in 2012, Analyst at Apothecary Capital LLC from 2010 to 2012, Portfolio Manager at Surveyor Capital Ltd. from 2016 to 2018, and Portfolio Manager at Citadel Enterprise Americas LLC.
Education includes an undergraduate degree from New York University, conferred in 2007.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOHAVEN LTD. 0,02% | 28/04/2026 | 22 662 ( 0,02% ) | 249 509 $ | 31/05/2026 |
| 01/12/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BIOHAVEN LTD. | Directeur/Membre du Conseil | 28/09/2022 |
| BENITEC BIOPHARMA INC. | Directeur/Membre du Conseil | 26/06/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. IV | Fondateur | 01/05/2023 |
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Fondateur | 01/05/2023 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Directeur/Membre du Conseil | 03/10/2022 |
| AKILI, INC. | Directeur/Membre du Conseil | 01/08/2022 |
| PROKIDNEY A | President | 01/07/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 16 |
|---|---|
Adage Capital Management LP
Adage Capital Management LP Investment ManagersFinance Adage manages ACP primarily through industry-specific portfolios that are managed by analyst/portfolio manager teams or individuals. The ACP aims to provide investors with compound annual long-term returns that outperform the returns of the S&P 500 Index. Their analysts focus on adding value by stock selection based on intra-industry fundamental analysis. In addition to taking long positions, the firm uses leverage, sells securities short, and invests in derivatives, US and non-US equities and private securities. | Finance |
Evercore, Inc.
Evercore, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
BBT Capital Management, Inc.
BBT Capital Management, Inc. Investment ManagersFinance BBT Capital Management manages multiple strategy funds that focus on event-driven arbitrage, long/short equity and fixed-income arbitrage strategies. | Finance |
Citadel Enterprise Americas LLC
Citadel Enterprise Americas LLC Investment ManagersFinance Citadel Enterprise invests in public equity, fixed income and alternative investment markets across the globe. The firm seeks to identify the highest and best uses of capital to generate superior long-term returns for their clients. | Finance |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apothecary Capital LLC
Apothecary Capital LLC Investment ManagersFinance Apothecary Capital focuses on investments in the healthcare sector | Finance |
Surveyor Capital Ltd.
Surveyor Capital Ltd. Investment Trusts/Mutual FundsMiscellaneous Surveyor Capital is a global, multi-manager equities strategy and is one of Citadel’s three fundamental equities businesses. Their sector-aligned investment teams conduct deep fundamental research, developing an independent view on the companies they cover. They are specialists in their industries and experts in their coverage, building trusted relationships with many corporate management teams. The firm's investment teams leverage Citadel’s proprietary, market-neutral risk framework with the aim of building portfolios that minimize broad market exposures. Using this insight, they act on their investment theses and scale their risk-taking with confidence. | Miscellaneous |
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
Benitec Biopharma, Inc.
Benitec Biopharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company and develops proprietary therapeutic technology platform | Health Technology |
Social Capital Suvretta Holdings Corp. I
Social Capital Suvretta Holdings Corp. I Financial ConglomeratesFinance Operates as blank check company | Finance |
Social Capital Suvretta Holdings Corp. II
Social Capital Suvretta Holdings Corp. II Financial ConglomeratesFinance Operates as blank check company | Finance |
Social Capital Suvretta Holdings Corp. III
Social Capital Suvretta Holdings Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
Social Capital Suvretta Holdings Corp. IV
Social Capital Suvretta Holdings Corp. IV Financial ConglomeratesFinance Operates as blank check company | Finance |
ProKidney Corp.
ProKidney Corp. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Akili, Inc.
Akili, Inc. Medical SpecialtiesHealth Technology Operates as a digital medicine company that uses video-game technology and neuroscience to create treatments for cognitive conditions | Health Technology |
Biohaven Ltd.
Biohaven Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national